Aducanumab and disease modifying treatments for Alzheimer's disease-Reference-Cited by-同舟云学术

Aducanumab and disease modifying treatments for Alzheimer's disease

Published:2021-07 Issue:3 Volume:25 Page:4-6
ISSN:1367-7543
Container-title:Progress in Neurology and Psychiatry
language:en
Short-container-title:Prog. Neurol. Psychiatry

Author:

Thomas Emily¹,Wasunna‐Smith Brenda¹,Kuruvilla Tarun¹

Affiliation:

1. Dr Thomas and Dr Wasunna‐Smith are both General Adult Psychiatry Specialist Registrars and Dr Kuruvilla is a Consultant in Old Age Psychiatry & Clinical Director for Dementia Research, all at Gloucestershire Health and Care NHS Foundation Trust, UK

Publisher

Wiley

Subject

Psychiatry and Mental health,Neurology (clinical),Neurology,Pshychiatric Mental Health

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/pnp.711

Reference19 articles.

1. World Health Organization (WHO). Dementia (www.who.int/news‐room/fact‐sheets/detail/dementia;accessed 21 July 2021).

2. Memantine

3. Immunization Therapy for Alzheimer Disease: A Comprehensive Review of Active Immunization Strategies

4. Immunotherapy for Alzheimer’s disease: hoops and hurdles

5. Clinical effects of A immunization (AN1792) in patients with AD in an interrupted trial

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Assessment of Mild Cognitive Impairment Using CogEvo: A Computerized Cognitive Function Assessment Tool;Journal of Primary Care & Community Health;2024-01

2. Mild Behavioral Impairment in Psychogeriatric Patients: Clinical Features and Psychopathology Severity;Journal of Clinical Medicine;2023-08-21

3. Artificial intelligence assisted identification of potential tau aggregation inhibitors: ligand- and structure-based virtual screening, in silico ADME, and molecular dynamics study;Molecular Diversity;2023-04-06

4. Validity and reliability of a computerized cognitive function evaluation battery (CogEvo) as a screening tool;Psychiatry and Clinical Neurosciences Reports;2023-01-06

5. Lecanemab for Alzheimer's disease: new hope or another false dawn?;Progress in Neurology and Psychiatry;2023-01